The PD-1 and CD28 molecules on T cells in peripheral blood are associated with the prognosis of patients with advanced breast cancer receiving paclitaxel chemotherapy

• Ji Yang,

  Roles Data curation, Software, Visualization, Writing – original draft

  Affiliation Basic Medicine Laboratory, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Shuxian Qu,

  Roles Formal analysis, Investigation

  Affiliation Department of Clinical Oncology, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Xinhui Qi,

  Roles Formal analysis, Investigation

  Affiliation Department of Clinical Oncology, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Yongming Liu,

  Roles Formal analysis, Investigation

  Affiliation Department of Clinical Oncology, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Jianing Qiu,

  Roles Formal analysis, Investigation

  Affiliation Department of Clinical Oncology, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Ying Yu,

  Roles Methodology, Validation

  Affiliation Basic Medicine Laboratory, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Yino Wang,

  Roles Formal analysis, Investigation

  Affiliations Department of Breast Surgery, the First Affiliated Hospital of China Medical University, China, Department of Breast Surgery, Anshan Tumor Hospital, China

  ⨯
• Zhendong Zheng ,

  Roles Conceptualization

  * E-mail: hyingy@sina.com (HY); gcp_zzd@sian.com (ZZ)

  Affiliation Department of Clinical Oncology, General Hospital of Northern Theater Command, Shenyang, China

  ⨯
• Huiying Yu

  Roles Conceptualization, Supervision, Writing – review & editing

  * E-mail: hyingy@sina.com (HY); gcp_zzd@sian.com (ZZ)

  Affiliation Basic Medicine Laboratory, General Hospital of Northern Theater Command, Shenyang, China

  https://orcid.org/0000-0002-8703-9754

  ⨯